Skip to main content
. 2023 Apr 11;23(6):212–220. doi: 10.1016/j.bjae.2023.02.003

Table 2.

Additional diagnosis and investigations to consider in specific groups of patients. ∗All investigations in this section should be performed irrespective of the cause of immunosuppression. Investigations for returning traveller and autoimmune encephalitis are specific to the condition under consideration. Acute disseminated encephalomyelitis (ADEM), John Cunningham virus (JC), Myelin oligodendrocyte glycoprotein (MOG), White cell count (WCC).

Group Disorder Investigations to consider
All patients CSF opening pressure
CSF WCC and differential
CSF protein
Paired CSF and serum glucose
CSF Gram stain
Blood and CSF cultures
CSF PCR for meningococcus, pneumococcus, HSV 1 and 2, VZV and enterovirus
Immunocompromised patients∗ HIV
After transplant
Haematological malignancy
Immunosuppressant therapy
CMV and EBV PCR
HHV 6/7 PCR
JC virus PCR
HIV serology
Toxoplasma serology with or without PCR
Cryptococcal antigen/India ink stain
Aspergillus PCR
Galactomannan
CSF M. tuberculosis culture and acid-fast bacilli PCR
Returning traveller Cerebral malaria
Flaviviridae
Japanese encephalitis
Dengue encephalitis
St Louis encephalitis
West Nile encephalitis
Tick-borne encephalitis
Togaviridae
Eastern encephalitis
Western encephalitis
Venezuelan encephalitis
Reoviridae
Colorado tick fever
Rhabdoviridae
Rabies encephalitis
Chandipura virus
Henipaviridae
Nipah virus
Rapid blood antigen test
Thick and thin blood films
CSF PCR/serology
CSF PCR/serology
CSF PCR/serology
CSF PCR/serology
CSF PCR/serology
CSF serology
CSF serology
CSF serology
CSF PCR/serology
CSF PCR/serology
CSF serology
CSF PCR/serology
Autoimmune encephalitis Anti-NMDA receptor encephalitis
Anti-VGKC complex encephalitis
Bickerstaff's encephalitis
Paraneoplastic encephalitis
Hashimoto's encephalitis
ADEM
Anti-NMDA receptor antibodies
Anti-VGKC complex antibodies
Anti-GQ1b antibodies
ANNA 1/Anti-Hu
ANNA 2/Anti-Ri
Anti-Ma1/Anti-Ma 2
Anti-amphiphysin
Anti-thyroid peroxidase antibodies
MOG antibodies